Article result template
I'm a little template short and blank. I link to void and keep hidden out.
2024-11-19T09:50:42+0000
Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 69% of retail investor accounts lose money when trading spread bets and CFDs with this provider. You should consider whether you understand how spread bets and CFDs work, and whether you can afford to take the high risk of losing your money.
Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 69% of retail investor accounts lose money when trading spread bets and CFDs with this provider. You should consider whether you understand how spread bets and CFDs work, and whether you can afford to take the high risk of losing your money.
I'm a little template short and blank. I link to void and keep hidden out.
2024-11-19T09:50:42+0000
Discover the potential of AstraZeneca, GlaxoSmithKline, and Hikma Pharmaceuticals - three leading UK pharma stocks with promising growth prospects and attractive dividends.
2024-09-06T12:07:26+0100
Discover the five best defensive stocks on the FTSE 100 to watch, based on highest market cap.
2024-04-29T11:03:00+0100
Watch out for China inflation as investors await more substantial market rescue measures from Beijing. US initial jobless claims, likely to be more interesting after recent US jobs growth smashed expectations.
2024-02-07T16:41:40+0000
Pharma giant AstraZeneca is expected to report solid numbers in its Q4 update, but more good news is needed to stabilise the share price after losses so far this year.
2024-02-05T13:32:26+0000
Overnight in Asia, indices mostly rose in the wake of a positive US performance on Tuesday. In Europe, indices also opened higher on Wednesday.
2023-12-27T10:00:29+0000
Novo Nordisk shares rose after data showed its weight loss drug led to protective cardiac benefits. IGTV financial analyst @AngelineOng hones in on the global obesity drug race.
2023-11-13T14:14:00+0000
The drug giant has purchased a potential blockbuster obesity drug from Chinese firm Eccogene
2023-11-11T11:11:04+0000